Correlation Between Centessa Pharmaceuticals and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Pharvaris BV, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Pharvaris.
Diversification Opportunities for Centessa Pharmaceuticals and Pharvaris
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Centessa and Pharvaris is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Pharvaris go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Pharvaris
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.01 times more return on investment than Pharvaris. However, Centessa Pharmaceuticals is 1.01 times more volatile than Pharvaris BV. It trades about 0.11 of its potential returns per unit of risk. Pharvaris BV is currently generating about 0.01 per unit of risk. If you would invest 690.00 in Centessa Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of 1,101 from holding Centessa Pharmaceuticals PLC or generate 159.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Pharvaris BV
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Pharvaris BV |
Centessa Pharmaceuticals and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Pharvaris
The main advantage of trading using opposite Centessa Pharmaceuticals and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Centessa Pharmaceuticals vs. Tff Pharmaceuticals | Centessa Pharmaceuticals vs. Eliem Therapeutics | Centessa Pharmaceuticals vs. Inhibrx | Centessa Pharmaceuticals vs. Enliven Therapeutics |
| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |